MAPK8 and neoplasm: Collectively, our results and previous reports suggested that ELFN1-AS1 in CRC cells might directly affect JNK signaling in NK cells to suppress the surface expression of NKG2D and GZMB resulting in a marked deficiency in tumor cytotoxicity.